Inhibiting inducible nitric oxide synthase with rutin reduces renal ischemia/reperfusion injury

Canadian Journal of Surgery

Volumn 56, Issue 1, 2013, Pages 6-14

  Korkmaz, Asli ^a   Kolankaya, Dürdane ^b  

^a Plant Protection Research Institute   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; BIOLOGICAL MARKER; CYCLIC GMP; DRUG DERIVATIVE; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LYSINE; N(6) (1 IMINOETHYL)LYSINE; N(6)-(1-IMINOETHYL)LYSINE; NITRATE; NITRITE; PROTECTIVE AGENT; RUTOSIDE; TYROSINE;

ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; INFUSION; KIDNEY; MALE; METABOLISM; NEPHRECTOMY; RAT; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; CYCLIC GMP; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; INFUSIONS, PARENTERAL; KIDNEY; LYSINE; MALE; NEPHRECTOMY; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; RUTIN; TYROSINE;

MLCS; MLOWN;

EID: 84875022363     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.004811     Document Type: Article

References (55)

1. Eldaif SM, Deneve JA, Wang N. Attenuation of renal ischemia- reperfusion injury by postconditioning involves adenosine receptor and protein kinase C activation. Transpl Int 10.1111/j.1432-2277 .2009.00949.x.
2. McMichael M, Moore RM. Ischemia-reperfusion injury pathophysiology. Part I. J Vet Emerg Crit Care 2004;14:231-41.
3. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int 1991;39:476-500.
4. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984;74:1156-64.
5. Waz WR, Van Liew JB, Feld LG. Nitric oxide methabolism following unilateral renal ischemia/reperfusion injury in rats. Pediatr Nephrol 1998;12:26-9.
6. Honda N, Hishida A. Pathophysiology of experimental nonoliguric acute renal failure. Kidney Int 1993;43:513-21.
7. Bonventre JV. Mediators of ischemic renal injury. Annu Rev Med 1988;39:531-44.
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
9. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993;54:171-8.
10. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 1995;369:131-5.
11. De Vente J, Hopkins DA, Markerin-Van Ittersum M, et al. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMPproducing structures in the rat brain. Neuroscience 1998;87:207-41.
12. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984;74:1156-64.
13. Rhoden EL, Rhoden CR, Mauri M et al. Experimental model of renal ischemia-reperfusion in rats: study of the stress oxidative induced by oxygen-derived free radicals. Braz J Urol 1999; 25: 431-6.
14. Roczniak A, Levine DZ, Burns KD. Localization of protein inhibitor of neuronal nitric oxide synthase in rat kidney. Am J Physiol Renal Physiol 2000;278:F702-7.
15. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 1997;30:311-33.
16. Mattson DL, Wu F. Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension 2000;35:337-41.
17. Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stres and progression of chronic renal failure. Semin Nephrol 2004;24:354-65.
18. Walker LM, Walker PD, Imam SZ, et al. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N6-(-1-iminoethyl)lysine. J Pharmacol Exp Ther 2000;295:417-22.
19. Chatterjee PK, Patel NSA, Sivarajah A. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 2003;63:853-65.
20. Joles JA, Vos IH, Grone HJ, et al. Inducible nitric oxide synthase in renal transplantation. Kidney Int 2002;61:872-5.
21. Chatterjee PK, Patel NSA, Kvale EO, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002;61:862-71.
22. Mark LA, Robinson AV, Schulak JA. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury. J Surg Res 2005;129:236-41.
23. Liaudet L, Soriano FG, Szabó C. Biology of nitric oxide signaling. Crit Care Med 2000;28(4 Suppl):N37-52.
24. Goligorsky MS, Brodsky SV, Noiri E. NO bioavailability, endothelial dysfunction and acute renal failure: new insights into pathophysioloy. Semin Nephrol 2004;24:316-23.
25. Lieberthal W. Biology of ischemic and toxic renal tubular injury: role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 1998;7:289-95.
26. Paller MS. Nitric-oxide-mediated renal epithelial cell injury during hypoxia and reoxygenation. Ren Fail 1998;20:459-69.
27. Peterson J, Dwyer J. Flavonoids: dietary occurrence and biochemical activity. Nutr Res 1998;18:1995-2018.
28. Manach C, Morand C, Demigné C, et al. Bioavalibility of rutin and quercetin in rats. FEBS Lett 1997;409:12-6.
29. Middleton E. Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998;439:175-82.
30. Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem 2001;1:569-90.
31. Nègre-Slvayre A, Affany A, Hariton CR. Additional antilipoperoxidant activities of alpha-tocopherol and ascorbic acid on membranelike systems are potentiated by rutin. Pharmacology 1991;42:262-72.
32. Bombardelli E, Morazzoni P. The flavonoids: new perspectives in biological activities and therapeutics. Chim Oggi 1993;11:25-8.
33. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988;37:837-41.
34. Milde J, Elstner EF, Graßmann J. Synergistic inhibition of lowdensity lipoprotein oxidation by rutin, γ-terpinene, and ascorbic acid. Phytomedicine 2004;11:105-13.
35. National Research Council. Guide for the care and use of laboratory animals. Washington: National Academy Press; 1996.
36. Waynforth HB, Flecknell PA. Experimental and surgical technique in the rat. 2nd ed. New York: Academic Press; 1992.
37. Girault I, Karu AE, Schaper M, et al. Immunodetection of 3-nitro -tyrosine in the liver of zymosan-treated rats with a new monoclonal antibody: comparison to analysis by HPLC. Free Radic Biol Med 2001; 31:1375-87.
38. McCord JM. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
39. Korkmaz A, Kolankaya D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res 2010; 164: 309-15.
40. Korkmaz A, Kolankaya D. The protective effects of ascorbic acid against renal ischemia-reperfusion injury in male rats. Ren Fail 2009;31:36-43.
41. Bonventure JV, Kelly KJ. Ischemia/reperfusion injury in transplantation. In: Tilney NL, Strom TB, Paul LC, editors. Transplantation biology: cellular and molecular aspects. Philadelphia (PA): Lippincott-Raven Publishers. 1996. p. 257.
42. Weight SC, Furness PN, Nicholson ML. Nitric oxide generation is increased in experimental warm ischemia-reperfusion injury. Br J Surg 1998;85:1663-8.
43. Weight SC, Furness PN, Nicholson ML. Biphasic role for nitric oxide in experimental renal warm ischemia-reperfusion injury. Br J Surg 1999;86:1039-46.
44. Viñas JL, Sola A, Genescà M, et al. NO and NOS isoforms in the development of apoptosis in renal ischemia/reperfusion. Free Radic Biol Med 2006;40:992-1003.
45. Zhang L, Looney CG, Qi WN. Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase. J Appl Physiol 2003;94:1473-8.
46. Noiri E, Peresleni T, Miller F, et al. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:2377-83.
47. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268 (5 Pt 1):L699-722.
48. Halliwell B, Aeschbach R, Loliger L, et al. The characterization of antioxidants. Food Chem Toxicol 1995;33:601-17.
49. DiMari J, Megyesi J, Udvarhelyi N, et al. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997;272(3 Pt 2):F292-7.
50. Inal M, Altinisik M, Bilgin D. The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 2002; 20:291-6.
51. Shoskes DA. Effect of bioflavonoid quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 1998;66:147-52.
52. Singh D, Chopra K. The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res 2004;50:187-93.
53. Nègre-Salvayre A, Mabile L, Delchambre J, et al. alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cell. Biol Trace Elem Res 1995;47:81-91.
54. Cos P, Calome M, Hu JP, et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 1998;61:71-6.
55. Neumayer C, Fügl A, Nanobashvili J, et al. Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscle. J Surg Res 2006;133:150-8.